197 related articles for article (PubMed ID: 4996937)
1. Role of adrenergic mechanisms in development and therapy of open-angled glaucoma.
Langham ME
Proc R Soc Med; 1971 Jun; 64(6):622-8. PubMed ID: 4996937
[No Abstract] [Full Text] [Related]
2. New developments in the adrenergic pharmacology of normal and glaucomatous eyes.
Langham ME
Trans Aust Coll Ophthalmol; 1969; 1():52-63. PubMed ID: 5401126
[No Abstract] [Full Text] [Related]
3. [Significance and therapy of glaucoma].
Bietti GB
Klin Monbl Augenheilkd; 1973 Mar; 162(3):281-95. PubMed ID: 4713728
[No Abstract] [Full Text] [Related]
4. Topical adrenergic potentiators in primary open-angle glaucoma.
Kitazawa Y
Am J Ophthalmol; 1972 Oct; 74(4):588-93. PubMed ID: 4403873
[No Abstract] [Full Text] [Related]
5. Studies of action mechanism of antiglaucoma drugs with a newly developed cat model.
Chiou GC; Liu HK; Trzeciakowski J
Life Sci; 1980 Dec 22-29; 27(25-26):2445-51. PubMed ID: 7219019
[No Abstract] [Full Text] [Related]
6. [On the ocular responses to norepinephrine and epinephrine in patients with primary open-angle glaucoma].
Kitazawa Y
Nippon Ganka Gakkai Zasshi; 1971 Mar; 75(3):1103-9. PubMed ID: 5102369
[No Abstract] [Full Text] [Related]
7. [Tonographical examination on the effect of glaucadrine in the treatment of open-angle glaucoma (author's transl)].
Dausch D; Meythaler H; Braun H
Klin Monbl Augenheilkd; 1973 Dec; 163(6):711-6. PubMed ID: 4788870
[No Abstract] [Full Text] [Related]
8. Influence of an adrenergic potentiator on the ocular response to catecholamines in primates and man.
Kitazawa Y; Langham ME
Nature; 1968 Sep; 219(5161):1376-8. PubMed ID: 4971171
[No Abstract] [Full Text] [Related]
9. Autonomic drugs in ophthalmology: some problems and promises. Section III: Sympathomimetic drugs.
Holland MG
Ann Ophthalmol; 1974 Sep; 6(9):875-8, 881-4, 887-8. PubMed ID: 4155259
[No Abstract] [Full Text] [Related]
10. Studies of aqueous humor dynamics in man. 3. Measurements in young normal subjects using norepinephrine and isoproterenol.
Gaasterland D; Kupfer C; Ross K; Gabelnick HL
Invest Ophthalmol; 1973 Apr; 12(4):267-79. PubMed ID: 4144360
[No Abstract] [Full Text] [Related]
11. Second round-table. Medical therapy of glaucoma.
Doc Ophthalmol; 1972 Nov; 33(1):245-69. PubMed ID: 4637224
[No Abstract] [Full Text] [Related]
12. Drugs and glaucoma.
Kupfer C
Ophthalmology; 1978 Mar; 85(3):233-9. PubMed ID: 566410
[No Abstract] [Full Text] [Related]
13. Adrenergic responses in the human eye.
Langham ME; Kitazawa Y; Hart RW
J Pharmacol Exp Ther; 1971 Oct; 179(1):47-55. PubMed ID: 4938137
[No Abstract] [Full Text] [Related]
14. Effects of cholinergic drugs and adrenergic drugs on aqueous humor formation in the rabbit eye.
Miichi H; Nagataki S
Jpn J Ophthalmol; 1982; 26(4):425-36. PubMed ID: 7166902
[TBL] [Abstract][Full Text] [Related]
15. A comparison of pilocarpine hydrochloride and epinephrine bitartrate.
Brounley DW
Ann Ophthalmol; 1971 Sep; 3(9):970-3 passim. PubMed ID: 5163788
[No Abstract] [Full Text] [Related]
16. Effects of norepinephrine, isoproterenol and sympathetic stimulation on aqueous humour dynamics in vervet monkeys.
Bill A
Exp Eye Res; 1970 Jul; 10(1):31-46. PubMed ID: 4989614
[No Abstract] [Full Text] [Related]
17. Early effects of single and repeated doses of L-epinephrine in man.
Kronfeld PC
Am J Ophthalmol; 1971 Dec; 72(6):1058-72. PubMed ID: 5128111
[No Abstract] [Full Text] [Related]
18. The effects of the catecholamines and related drugs on intraocular pressure.
Ross RA; Drance SM
Can J Ophthalmol; 1975 Apr; 10(2):162-7. PubMed ID: 1125841
[TBL] [Abstract][Full Text] [Related]
19. Effect of L-norepinephrine and adrenergic potentiators on the aqueous humor dynamics of man.
Pollack IP
Am J Ophthalmol; 1973 Nov; 76(5):641-7. PubMed ID: 4748184
[No Abstract] [Full Text] [Related]
20. Receptor paralyzing agents applied in the treatment of glaucoma simplex.
Weinstein P
Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):374-5. PubMed ID: 4391519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
